InterCure Ltd. (INCR) Financials

INCR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2024 212.9 million 89.2 million
June 30, 2023 228.2 million 85.2 million
March 31, 2023 266.2 million 121.3 million
Dec. 31, 2022 248.6 million 100.1 million

INCR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2024 ? 31670
June 30, 2023 257221 257221
March 31, 2023 10.7 million 759882
Dec. 31, 2022 10.9 million 776545

INCR Net Income

No data available :(

INCR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2024 27.4 million - -
June 30, 2023 27.9 million - 5.8 million
March 31, 2023 64.7 million - 6.2 million
Dec. 31, 2022 30.3 million - 7.8 million

INCR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2024 12.1 million
June 30, 2023 11.6 million
March 31, 2023 12.6 million
Dec. 31, 2022 12.9 million

INCR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2024 - 17865 2.8 million 3.4 million
June 30, 2023 1031 26833 3.1 million 3.9 million
March 31, 2023 1.3 million 48343 16.2 million 9.8 million
Dec. 31, 2022 1.3 million 49403 16.6 million 10.0 million

INCR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2024 19.9 million 15.0 million
June 30, 2023 27.8 million 18.9 million
March 31, 2023 29.3 million 22.2 million
Dec. 31, 2022 30.0 million 22.6 million

INCR

Price: $1.02

52 week price:
0.68
1.77

Earnings Per Share: -0.50 USD

P/E Ratio: -1.64

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Israel

Volume: 6941

Ebitda: 98.4 million

Market Capitalization: 56.9 million

Links: